ABK-CA-PROT-85
Phase N/A
OPEN TO ACCRUAL
Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)
AZ-D933GC00002-EMERALD-Y90
Phase II
OPEN TO ACCRUAL
Phase II Single-Arm Study of Durvalumab and Bevacizumab Following Transarterial Radioembolization Using Yttrium-90 Glass Microspheres (TheraSphere) in Unresectable Hepatocellular Carcinoma Amenable to Locoregional Therapy